Will migraine drug approval make Teva a success again?
The U.S. Food and Drug Administration approved a new migraine treatment Teva created, which has potentially 39 million Americans buyers.
An Israeli flag flutters near the logo of Teva Tech which is part of Teva Pharmaceutical Industries in Neot Hovav, southern Israel December 14, 2017.(photo credit: REUTERS/AMIR COHEN)ByREUTERS, TNS
